Institutional

For over one hundred years, we have believed in all types of innovation, from market trends and new client products and services … Meet our new visual identity!

As part of its Social Responsibility Program, Kasznar Leonardos donated over 700 packages of basic foodstuffs through the “Gramachinhos” Project in Rio … Kasznar Leonardos donates basic foodstuffs to families in Rio de Janeiro and Sao Paulo

In May 2020, Kasznar Leonardos implemented its Diversity and Inclusion Program aiming to create a more inclusive work environment. Over the past … Kasznar Leonardos celebrates the first year of its Diversity & Inclusion Program

Kasznar Leonardos is pleased to announce the promotion of three new partners, effective January 2021. Ísis Valaziane and Luciana Minada will become … New partners for Litigation and Patents

Based in New York City, Marcel will help strengthen our capabilities in the US and Asian markets by helping our clients to … Kasznar Leonardos welcomes Marcel Nadal Michelman as our Of Counsel in the USA

With more than 20 years' experience in legal and intellectual property areas, Maria Pia Guerra has joined our firm as Executive Director of our international unit I’B The IP Hub

Rosane Tavares has more than 30 years' experience in Intellectual Property.

On April 17, 2018 the Superior Court of Justice had the opportunity to analyze the first Special Appeal addressing the term of … Brazilian Superior Court of Justice decides its first mailbox case

In a decision made available on the 7th of November, Judge of the Supreme Court Luiz Fux dismissed a lawsuit by which … Supreme Court dismisses lawsuit against rule that guarantees a minimum term for patent protection

On August 8 2017 ANVISA officially published the new Rule RDC Nº 168, related to the prior consent of the Agency on patent applications for pharmaceutical products and processes, regulated by Joint Ordinance ANVISA-INPI No. 1, dated April 12, 2017, aiming to a more efficient way to analyze patent applications.